It's Been Over 7 Weeks, and Fed Chair Kevin Warsh Has Failed to Make Any Headway on a Key Central Bank Reform

Kevin Warsh was sworn in as Fed chair on May 22, but has made no progress on shrinking the Fed’s balance sheet—total Fed assets at the banking system rose from $6.704T (May 27) to about $6.725T (July 1). The article notes that reducing the balance sheet would lift long-term yields and increase borrowing costs without changing the federal funds target rate, and links higher financing costs to a potential reset of equity valuations fueled by AI data-center buildouts. With inflation cited at 4.2% in May, the delayed balance-sheet deleveraging is framed as a headwind for stocks priced at historically high levels.

Analysis

The market impact is less about the policy rate and more about the term premium: a persistent balance-sheet unwind or even a credible commitment to stop reinvesting would raise the cost of capital for every 3- to 10-year cash-flow story. That is structurally negative for high-multiple AI beneficiaries like NVDA because the first-order hit is not unit demand, but the second-order hit is customer capex payback hurdles and the willingness of hyperscalers to pre-commit to multi-year buildouts.

The more interesting spillover is to index composition. A handful of mega-cap growth names carry a disproportionate share of the benchmark’s valuation support, so even a modest move in real yields can mechanically compress the S&P 500’s multiple without any earnings downgrades. That makes the risk asymmetrical over the next 1-3 months: if long rates back up, passive flows can reverse from a strength source into a volatility amplifier.

Contrarian take: the immediate move may be overstated because speech-level hawkishness is cheaper than actual runoff, and the Fed has a long history of pausing QT at the first sign of funding stress. The real falsifier is not rhetoric but market plumbing — if Treasury auctions stop tailing, credit spreads widen, or repo stresses surface, the Fed will likely slow the balance-sheet path before it meaningfully dents growth; if not, the slower-burn valuation hit lasts 6-18 months.

Key Decisions for Investors

• Buy NVDA 1-3 month put spreads on strength; use the trade as a valuation/discount-rate hedge rather than a fundamental chip-demand short. Risk/reward improves if 10Y real yields keep making new highs; invalidate on repeated upside guidance revisions or a pause in QT rhetoric.
• Short QQQ against a smaller long in defensives/cash-flow-rich sectors if available; the point is to isolate duration sensitivity rather than an outright market call. Expect the underperformance to show up first in the next 2-6 weeks through multiple compression, not earnings misses.
• Add a tactical short TLT if the Fed continues balance-sheet expansion into month-end; this is the cleanest expression of higher term premium. Falsify the thesis if the Fed signals active reinvestment slowdowns or if growth data rolls over enough to drag yields lower.
• Keep OZK on a watch list for funding-cost and liquidity pressure rather than as an immediate trade; regional banks can look fine on net interest margin while asset-liability duration and deposit competition quietly worsen. Reassess if credit spreads widen or if bank loan growth decelerates for two consecutive months.